These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2775937)

  • 21. The nature of hyperthermia in neuroleptic malignant syndrome and the use of bromocriptine.
    Gillman PK
    J Med Toxicol; 2010 Jun; 6(2):272-3. PubMed ID: 20361363
    [No Abstract]   [Full Text] [Related]  

  • 22. Diagnosing and treating neuroleptic malignant syndrome.
    Am J Psychiatry; 1986 May; 143(5):673-5. PubMed ID: 2870651
    [No Abstract]   [Full Text] [Related]  

  • 23. [Beneficial effect of bromocriptine in a patient with malignant syndrome and hepatic dysfunctions].
    Onaka A; Aibiki M; Shirakawa Y; Chikano S; Yokono S; Ogli K
    Masui; 1993 Mar; 42(3):431-4. PubMed ID: 8468790
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuroleptic malignant syndrome in cycloserine-induced psychosis.
    Sawant NS; Kate NS; Bhatankar SS; Kulkarni PS
    Indian J Pharmacol; 2015; 47(3):328-9. PubMed ID: 26069374
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clozapine-associated neuroleptic malignant syndrome followed by catatonia: a case report].
    Erol A; Putgül G; Sert E; Mete L
    Turk Psikiyatri Derg; 2013; 24(2):140-4. PubMed ID: 23754268
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuroleptic malignant syndrome.
    Goldwasser HD; Hooper JF
    Am Fam Physician; 1988 Nov; 38(5):211-6. PubMed ID: 3189125
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Case report: Neuroleptic malignant syndrome and diagnostic difficulties].
    Khouri C; Planès S; Logerot S; Villier C; Mallaret M
    Encephale; 2016 Jun; 42(3):277-80. PubMed ID: 26923996
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intravenous administration of lisuride in the treatment of neuroleptic malignant syndrome.
    de Mari M; Lamberti P; Simone F; Iliceto G; Federico F; Ferrari E
    Funct Neurol; 1991; 6(3):285-8. PubMed ID: 1683852
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Distinguishing neuroleptic malignant syndrome (NMS) from NMS-like acute medical illnesses: a study of 34 cases.
    Sewell DD; Jeste DV
    J Neuropsychiatry Clin Neurosci; 1992; 4(3):265-9. PubMed ID: 1354002
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuroleptic malignant syndrome and acute myocardial infarction: case report and review.
    Freedman MD
    Md Med J; 1997 Aug; 46(7):357-9. PubMed ID: 9260471
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuroleptic malignant syndrome responsive to carbidopa/levodopa: support for a dopaminergic pathogenesis.
    Harris M; Nora L; Tanner CM
    Clin Neuropharmacol; 1987 Apr; 10(2):186-9. PubMed ID: 3503673
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Acute renal failure in neuroleptic malignant syndrome].
    Wagner G; Rónai L
    Orv Hetil; 1995 Oct; 136(40):2173-6. PubMed ID: 7566952
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aripiprazole-induced quasi-neuroleptic malignant syndrome: two case reports.
    Osman AHM; Wilkinson J
    J Med Case Rep; 2024 Apr; 18(1):190. PubMed ID: 38632633
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuroleptic malignant syndrome associated with amoxapine and lithium in an older adult.
    Gupta S; Racaniello AA
    Ann Clin Psychiatry; 2000 Jun; 12(2):107-9. PubMed ID: 10907803
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The treatment of neuroleptic malignant syndrome. Are dantrolene and bromocriptine useful adjuncts to supportive care?
    Rosebush PI; Stewart T; Mazurek MF
    Br J Psychiatry; 1991 Nov; 159():709-12. PubMed ID: 1843801
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Suspected neuroleptic malignant syndrome in a patient receiving clozapine.
    Ganelin L; Lichtenberg PS; Marcus EL; Munter RG
    Ann Pharmacother; 1996 Mar; 30(3):248-50. PubMed ID: 8833560
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuroleptic malignant syndrome: guidelines for treatment and reinstitution of neuroleptics.
    Olmsted TR
    South Med J; 1988 Jul; 81(7):888-91. PubMed ID: 2899358
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The myth of elevated serum creatine phosphokinase level and neuroleptic malignant syndrome.
    Adityanjee
    Br J Psychiatry; 1991 May; 158():706-7. PubMed ID: 1677602
    [No Abstract]   [Full Text] [Related]  

  • 39. [Malignant neuroleptic syndrome treated with bromocriptine].
    Fernández Ballesteros A; Cervero Jiménez M; Marco Martínez J; Martín Joven A
    Rev Clin Esp; 1993 Jan; 192(1):49. PubMed ID: 8465032
    [No Abstract]   [Full Text] [Related]  

  • 40. Neuroleptic malignant syndrome.
    Levenson JL
    Am J Psychiatry; 1985 Oct; 142(10):1137-45. PubMed ID: 2863986
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.